Aramark (NYSE: ARMK) director gains 140.464 dividend equivalent rights

Rhea-AI Filing Summary

Aramark director Susan M. Cameron acquired additional stock-based rights. On this Form 4, she received 140.464 dividend equivalent rights tied to Aramark common stock at a stated price of 0.0000 per share-equivalent. Following this award, she directly holds a total of 48,226.121 shares and related units. According to the disclosure, these dividend equivalent rights were credited on deferred stock units in connection with Aramark’s quarterly dividend and will vest on the same schedules as the underlying awards.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider CAMERON SUSAN M.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	140.464	$0.00	--

Holdings After Transaction: Common Stock — 48,226.121 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CAMERON SUSAN M.

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		A		140.464(1)	A	$0	48,226.121	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Aramark (ARMK) report for Susan M. Cameron?

Aramark reported that director Susan M. Cameron acquired 140.464 dividend equivalent rights linked to Aramark common stock. These rights were credited in connection with the company’s quarterly dividend on deferred stock units she already holds.

How many Aramark (ARMK) shares and related units does Susan M. Cameron hold after this Form 4?

After this transaction, Susan M. Cameron directly holds a total of 48,226.121 Aramark common shares and related stock-based units. This figure includes the newly credited 140.464 dividend equivalent rights reported in the filing.

What is the nature of the 140.464 units reported in Susan M. Cameron’s Aramark (ARMK) Form 4?

The 140.464 units are dividend equivalent rights credited on deferred stock units in connection with Aramark’s quarterly dividend. They are tied to common stock and are treated similarly to additional stock-based units for the reporting person.

At what price were the dividend equivalent rights granted to Susan M. Cameron at Aramark (ARMK)?

The 140.464 dividend equivalent rights were reported with a stated transaction price of 0.0000 per share-equivalent. This reflects that they accrued automatically as dividend equivalents on existing deferred stock unit awards.

How do the dividend equivalent rights for Aramark (ARMK) director Susan M. Cameron vest?

According to the disclosure, the dividend equivalent rights granted to Susan M. Cameron vest on the same schedules as the underlying deferred stock unit awards. Their vesting follows the original award timelines rather than a separate schedule.

Is Susan M. Cameron’s ownership in Aramark (ARMK) direct or indirect in this Form 4?

The filing states that Susan M. Cameron’s post-transaction holdings of 48,226.121 units are held with direct ownership. The ownership code is listed as “D,” indicating direct rather than indirect beneficial ownership.